97.95 % on L-Glutathione (reduced) is below the index specification for the class. The interesting part is the distribution: cysteinyl-glycine (−129 Da) at 1.31 % is doing most of the work, and that species is a synthesis artefact rather than a degradation product. This is a process observation about lot WXT-2605-B3833, not a storage one.
pseudoproline
Pseudoproline dipeptides and aggregation-prone sequence stretches.
Section 1
Contribution
Comments technically on records submitted by others. Annotations are signed and are not moderated for agreement.
Records submitted
0
n=0
Annotations
4
n=4
Median purity submitted
suppressed
n=0
n<3 — see individual records
Suppliers covered
0
n=0
This handle has submitted no records. Annotators comment on other people's submissions and are not required to submit.
Section 2
Annotations
Signed technical comments on records. The index does not moderate annotations for agreement with its own arithmetic, and several of these disagree with it. Where a handle has made the same point on several records, one instance is shown and the rest are reachable from the records themselves.
97.13 % on Liraglutide is below the index specification for the class. The interesting part is the distribution: palmitoyl bis-adduct (+238 Da) at 2.02 % is doing most of the work, and that species is a synthesis artefact rather than a degradation product. This is a process observation about lot CPC-2602-G9942, not a storage one.
Sequences with an aggregation-prone stretch respond to a pseudoproline dipeptide at the right position. Where a compound recurs in this band across suppliers, that is usually the reason rather than any one plant.
98.80 % on GHRP-2 is below the index specification for the class. The interesting part is the distribution: oxidised Trp (+16 Da) at 0.69 % is doing most of the work, and that species is a synthesis artefact rather than a degradation product. This is a process observation about lot GGPE-2406-F1736, not a storage one.